Executive Summary

According to GRD Survey data, the global Drugs for External Use market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2029, growing at a CAGR of % in the forecast period between from 2023 to 2029.

This report studies the Drugs for External Use market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Drugs for External Use in these regions, from 2017 to 2029, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Lotion
Ointment
Tincture
Other

Market Snapshot, By Application
Hospital
Clinic
Other

Main Market Players Analyzed in this report, including:
Yunnan Baiyao
Yulin
Wantong Group
Tianhe
Shengyang Hongyao
MUHI
LKF
Linrui
JNJ
Hubiao
Huahong Pharma
Hisamitsu
GSK
Cheezheng

The study objectives of this report are:
To study and analyze the global Drugs for External Use market size (value & volume) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2029.
To understand industry structure of Drugs for External Use market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Drugs for External Use manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for External Use market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Drugs for External Use submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for External Use are as follows:
History Year: 2017-2021
Base Year: 2021
Estimated Year: 2023
Forecast Year 2023 to 2029

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Drugs for External Use Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Drugs for External Use Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Drugs for External Use

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Drugs for External Use Sales Channel and Distributors Analysis
3.3.1 Drugs for External Use Sales Channel
3.3.2 Drugs for External Use Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospital
3.4.2 Major Buyers in Clinic
3.5 Drugs for External Use Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Drugs for External Use Type Introduction
4.1.1 Lotion
4.1.2 Ointment
4.1.3 Tincture
4.1.4 Other
4.2 Global Drugs for External Use Sales by Type 2017-2023
4.3 Global Drugs for External Use Revenue by Type 2017-2023
4.4 Global Drugs for External Use Price by Type 2017-2023

5 Market Segment: by Application
5.1 Drugs for External Use Type Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Drugs for External Use Sales by Application 2017-2023
5.3 Global Drugs for External Use Revenue by Application 2017-2023
5.4 Global Drugs for External Use Price by Application 2017-2023

6 Marke Segment: by Region
6.1 Global Drugs for External Use Market by Region
6.1.1 Global Drugs for External Use Sales by Regions
6.1.2 Global Drugs for External Use Revenue by Regions
6.2 North America Drugs for External Use Market 2017-2023
6.3 Europe Drugs for External Use Market 2017-2023
6.4 Asia Pacific Drugs for External Use Market 2017-2023
6.5 South America Drugs for External Use Market 2017-2023
6.6 Middle East and Africa Drugs for External Use Market 2017-2023

7 North America
7.1 North America Drugs for External Use Market by Country 2017-2023
7.1.1 North America Drugs for External Use Sales by Country
7.1.2 North America Drugs for External Use Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Drugs for External Use Market by Country 2017-2023
8.1.1 Europe Drugs for External Use Sales by Country
8.1.2 Europe Drugs for External Use Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Drugs for External Use Market by Country 2017-2023
9.1.1 Asia Pacific Drugs for External Use Sales by Country
9.1.2 Asia Pacific Drugs for External Use Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Drugs for External Use Market by Country 2017-2023
10.1.1 South America Drugs for External Use Sales by Country
10.1.2 South America Drugs for External Use Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Drugs for External Use Market by Country 2017-2023
11.1.1 Middle East and Africa Drugs for External Use Sales by Country
11.1.2 Middle East and Africa Drugs for External Use Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Yunnan Baiyao
12.1.1 Yunnan Baiyao Company Information
12.1.2 Yunnan Baiyao Drugs for External Use Product Portfolio, Specification and Application
12.1.3 Yunnan Baiyao Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Yunnan Baiyao Key Development
12.2 Yulin
12.2.1 Yulin Company Information
12.2.2 Yulin Drugs for External Use Product Portfolio, Specification and Application
12.2.3 Yulin Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Yulin Key Development
12.3 Wantong Group
12.3.1 Wantong Group Company Information
12.3.2 Wantong Group Drugs for External Use Product Portfolio, Specification and Application
12.3.3 Wantong Group Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Wantong Group Key Development
12.4 Tianhe
12.4.1 Tianhe Company Information
12.4.2 Tianhe Drugs for External Use Product Portfolio, Specification and Application
12.4.3 Tianhe Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Tianhe Key Development
12.5 Shengyang Hongyao
12.5.1 Shengyang Hongyao Company Information
12.5.2 Shengyang Hongyao Drugs for External Use Product Portfolio, Specification and Application
12.5.3 Shengyang Hongyao Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Shengyang Hongyao Key Development
12.6 MUHI
12.6.1 MUHI Company Information
12.6.2 MUHI Drugs for External Use Product Portfolio, Specification and Application
12.6.3 MUHI Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 MUHI Key Development
12.7 LKF
12.7.1 LKF Company Information
12.7.2 LKF Drugs for External Use Product Portfolio, Specification and Application
12.7.3 LKF Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 MUHI Key Development
12.9 JNJ
12.9.1 JNJ Company Information
12.9.2 JNJ Drugs for External Use Product Portfolio, Specification and Application
12.9.3 JNJ Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 JNJ Key Development
12.8 Linrui
12.8.1 Linrui Company Information
12.8.2 Linrui Drugs for External Use Product Portfolio, Specification and Application
12.8.3 Linrui Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Linrui Key Development
12.11 Huahong Pharma
12.11.1 Huahong Pharma Company Information
12.11.2 Huahong Pharma Drugs for External Use Product Portfolio, Specification and Application
12.11.3 Huahong Pharma Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Huahong Pharma Key Development
12.12 Hisamitsu
12.12.1 Hisamitsu Company Information
12.12.2 Hisamitsu Drugs for External Use Product Portfolio, Specification and Application
12.12.3 Hisamitsu Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Hisamitsu Key Development
12.13 GSK
12.13.1 GSK Company Information
12.13.2 GSK Drugs for External Use Product Portfolio, Specification and Application
12.13.3 GSK Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 GSK Key Development
12.14 Cheezheng
12.14.1 Cheezheng Company Information
12.14.2 Cheezheng Drugs for External Use Product Portfolio, Specification and Application
12.14.3 Cheezheng Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Cheezheng Key Development

13 Global Drugs for External Use Market Forecast by Region by Type and by Application
13.1 Global Drugs for External Use Sales, Revenue Forecast 2023-2029
13.2 Global Drugs for External Use Forecast by Regions
13.2.1 Global Drugs for External Use Sales Forecast by Region 2023-2029
13.2.2 Global Drugs for External Use Revenue Forecast by Region 2023-2029
13.3 Global Drugs for External Use Forecast by Type
13.3.1 Global Drugs for External Use Sales Forecast by Type 2023-2029
13.3.2 Global Drugs for External Use Revenue Forecast by Type 2023-2029
13.3.3 Global Drugs for External Use Price Forecast by Type 2023-2029
13.4 Global Drugs for External Use Forecast by Application
13.4.1 Global Drugs for External Use Sales Forecast by Application 2023-2029
13.4.2 Global Drugs for External Use Revenue Forecast by Application 2023-2029
13.4.3 Global Drugs for External Use Price Forecast by Application 2023-2029

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Tables

Table 1: Global Drugs for External Use Production Specifications
Table 2: Drivers in Drugs for External Use Market
Table 3: Restraints Drugs for External Use Market
Table 4: Opportunity in Drugs for External Use Market
Table 5: Comparion of Alternative and Drugs for External Use
Table 6: Drugs for External Use Raw Materials Key Suppliers List
Table 7: Drugs for External Use Distributors List
Table 8: Drugs for External Use Major Buyers in Hospital
Table 9: Drugs for External Use Major Buyers in Clinic
Table 10: Drugs for External Use Major Buyers in Other
Table 11: Global Drugs for External Use Sales (K Units) by Type 2017-2023
Table 12: Global Drugs for External Use Sales Market Share by Type 2017-2023
Table 13: Global Drugs for External Use Revenue (Million USD) by Type 2017-2023
Table 14: Global Drugs for External Use Revenue Market Share by Type 2017-2023
Table 15: Global Drugs for External Use Price by Type 2017-2023
Table 16: Global Drugs for External Use Sales (K Units) by Application 2017-2023
Table 17: Global Drugs for External Use Sales Market Share by Application 2017-2023
Table 18: Global Drugs for External Use Revenue (Million USD) by Application 2017-2023
Table 19: Global Drugs for External Use Revenue Market Share by Application 2017-2023
Table 20: Global Drugs for External Use Price by Application 2017-2023
Table 21: Global Drugs for External Use Sales (K Units) by Region 2017-2023
Table 22: Global Drugs for External Use Sales Market Share by Region 2017-2023
Table 23: Global Drugs for External Use Revenue (Million USD) by Region 2017-2023
Table 24: Global Drugs for External Use Revenue Market Share by Region 2017-2023
Table 25: North America Drugs for External Use Sales (K Units) by Country 2017-2023
Table 26: North America Drugs for External Use Sales Market Share by Country 2017-2023
Table 27: North America Drugs for External Use Revenue (Million USD) by Country 2017-2023
Table 28: North America Drugs for External Use Revenue Market Share by Country 2017-2023)
Table 29: Europe Drugs for External Use Sales (K Units) by Country 2017-2023
Table 30: Europe Drugs for External Use Sales Market Share by Country 2017-2023
Table 31: Europe Drugs for External Use Revenue (Million USD) by Country 2017-2023
Table 32: Europe Drugs for External Use Revenue Market Share by Country 2017-2023)
Table 33: Asia Pacific Drugs for External Use Sales (K Units) by Country 2017-2023
Table 34: Asia Pacific Drugs for External Use Sales Market Share by Country 2017-2023
Table 35: Asia Pacific Drugs for External Use Revenue (Million USD) by Country 2017-2023
Table 36: Asia Pacific Drugs for External Use Revenue Market Share by Country 2017-2023)
Table 37: South America Drugs for External Use Sales (K Units) by Country 2017-2023
Table 38: South America Drugs for External Use Sales Market Share by Country 2017-2023
Table 39: South America Drugs for External Use Revenue (Million USD) by Country 2017-2023
Table 40: South America Drugs for External Use Revenue Market Share by Country 2017-2023)
Table 41: Middle East and Africa Drugs for External Use Sales (K Units) by Country 2017-2023
Table 42: Middle East and Africa Drugs for External Use Sales Market Share by Country 2017-2023
Table 43: Middle East and Africa Drugs for External Use Revenue (Million USD) by Country 2017-2023
Table 44: Middle East and Africa Drugs for External Use Revenue Market Share by Country 2017-2023)
Table 45 Yunnan Baiyao Company Information
Table 46 Yunnan Baiyao Drugs for External Use Product Portfolio, Specification and Application
Table 47 Yunnan Baiyao Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Yulin Company Information
Table 49 Yulin Drugs for External Use Product Portfolio, Specification and Application
Table 50 Yulin Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Wantong Group Company Information
Table 52 Wantong Group Drugs for External Use Product Portfolio, Specification and Application
Table 53 Wantong Group Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Tianhe Company Information
Table 55 Tianhe Drugs for External Use Product Portfolio, Specification and Application
Table 56 Tianhe Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Shengyang Hongyao Company Information
Table 58 Shengyang Hongyao Drugs for External Use Product Portfolio, Specification and Application
Table 59 Shengyang Hongyao Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 MUHI Company Information
Table 61 MUHI Drugs for External Use Product Portfolio, Specification and Application
Table 62 MUHI Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 LKF Company Information
Table 64 LKF Drugs for External Use Product Portfolio, Specification and Application
Table 65 LKF Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Linrui Company Information
Table 67 Linrui Drugs for External Use Product Portfolio, Specification and Application
Table 68 Linrui Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 JNJ Company Information
Table 70 JNJ Drugs for External Use Product Portfolio, Specification and Application
Table 71 JNJ Drugs for External Use Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Drugs for External Use Sales (K Units) Forecast by Region (2023-2029)
Table 73: Global Drugs for External Use Sales Market Share Forecast by Region (2023-2029)
Table 74: Global Drugs for External Use Revenue (Million USD) Forecast by Region (2023-2029)
Table 75: Global Drugs for External Use Revenue Market Share Forecast by Region (2023-2029)
Table 76: Global Drugs for External Use Sales (K Units) Forecast by Type (2023-2029)
Table 77: Global Drugs for External Use Sales Market Share Forecast by Type (2023-2029)
Table 78: Global Drugs for External Use Revenue (Million USD) Forecast by Type (2023-2029)
Table 79: Global Drugs for External Use Revenue Market Share Forecast by Type (2023-2029)
Table 80: Global Drugs for External Use Sales (K Units) Forecast by Applicaion (2023-2029)
Table 81: Global Drugs for External Use Sales Market Share Forecast by Application (2023-2029)
Table 82: Global Drugs for External Use Revenue (Million USD) Forecast by Application (2023-2029)
Table 83: Global Drugs for External Use Revenue Market Share Forecast by Application (2023-2029)




List of Figures

Figure 1: Drugs for External Use Picture
Figure 2: Global Drugs for External Use Market Size (Million USD) and Growth Rate (2017-2029)
Figure 3: Porter's Five Forces Analysis
Figure 4: Drugs for External Use Supply Chain Analysis
Figure 5: Drugs for External Use Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Lotion
Figure 7: Product Picture of Ointment
Figure 8: Global Drugs for External Use Sales Market Share by Type, 2021
Figure 9: Global Drugs for External Use Revenue Market Share by Type, 2021
Figure 10: Drugs for External Use in Hospital
Figure 11: Global Drugs for External Use Market: Hospital 2017-2023
Figure 12: Drugs for External Use in Clinic
Figure 13: Global Drugs for External Use Market: Clinic 2017-2023
Figure 14: Global Drugs for External Use Sales Market Share by Application, 2021
Figure 15: Global Drugs for External Use Revenue Market Share by Application, 2021
Figure 16: Global Drugs for External Use Sales Market Share by Region 2017-2023
Figure 17: Global Drugs for External Use Revenue Market Share by Region 2017-2023
Figure 18: North America Drugs for External Use Sales (K Units) Status 2017-2023
Figure 19: North America Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 20: Europe Drugs for External Use Sales (K Units) Status 2017-2023
Figure 21: Europe Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 22: Asia Pacific Drugs for External Use Sales (K Units) Status 2017-2023
Figure 23: Asia Pacific Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 24: South America Drugs for External Use Sales (K Units) Status 2017-2023
Figure 25: South America Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 26: Middle East and Africa Drugs for External Use Sales (K Units) Status 2017-2023
Figure 27: Middle East and Africa Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 28: North America Drugs for External Use Sales Market Share by Country, 2021
Figure 29: North America Drugs for External Use Revenue Market Share by Country, 2021
Figure 30: United States Drugs for External Use Sales (K Units) Status 2017-2023
Figure 31: United States Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 32: Canada Drugs for External Use Sales (K Units) Status 2017-2023
Figure 33: Canada Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 34: Mexico Drugs for External Use Sales (K Units) Status 2017-2023
Figure 35: Mexico Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 36: Europe Drugs for External Use Sales Market Share by Country, 2021
Figure 37: Europe Drugs for External Use Revenue Market Share by Country, 2021
Figure 38: Germany Drugs for External Use Sales (K Units) Status 2017-2023
Figure 39: Germany Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 40: France Drugs for External Use Sales (K Units) Status 2017-2023
Figure 41: France Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 42: UK Drugs for External Use Sales (K Units) Status 2017-2023
Figure 43: UK Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 44: Italy Drugs for External Use Sales (K Units) Status 2017-2023
Figure 45: Italy Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 46: Russia Drugs for External Use Sales (K Units) Status 2017-2023
Figure 46: Russia Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 47: Spain Drugs for External Use Sales (K Units) Status 2017-2023
Figure 48: Spain Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 49: Asia Pacific Drugs for External Use Sales Market Share by Country, 2021
Figure 50: Asia Pacific Drugs for External Use Revenue Market Share by Country, 2021
Figure 51: China Drugs for External Use Sales (K Units) Status 2017-2023
Figure 52: China Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 53: Japan Drugs for External Use Sales (K Units) Status 2017-2023
Figure 54: Japan Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 55: Korea Drugs for External Use Sales (K Units) Status 2017-2023
Figure 56: Korea Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 57: Southeast Asia Drugs for External Use Sales (K Units) Status 2017-2023
Figure 58: Southeast Asia Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 59: India Drugs for External Use Sales (K Units) Status 2017-2023
Figure 60: India Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 61: Australia Drugs for External Use Sales (K Units) Status 2017-2023
Figure 62: Australia Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 63: South America Drugs for External Use Sales Market Share by Country, 2021
Figure 64: South America Drugs for External Use Revenue Market Share by Country, 2021
Figure 65: Brazil Drugs for External Use Sales (K Units) Status 2017-2023
Figure 66: Brazil Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 67: Argentina Drugs for External Use Sales (K Units) Status 2017-2023
Figure 68: Argentina Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 69: Colombia Drugs for External Use Sales (K Units) Status 2017-2023
Figure 70: Colombia Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 71: Middle East and Africa Drugs for External Use Sales Market Share by Country, 2021
Figure 72: Middle East and Africa Drugs for External Use Revenue Market Share by Country, 2021
Figure 73: Turkey Drugs for External Use Sales (K Units) Status 2017-2023
Figure 74: Turkey Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 75: Saudi Arabia Drugs for External Use Sales (K Units) Status 2017-2023
Figure 76: Saudi Arabia Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 77: South Africa Drugs for External Use Sales (K Units) Status 2017-2023
Figure 78: South Africa Drugs for External Use Revenue (Million USD) Status 2017-2023
Figure 79: Yunnan Baiyao Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 80: Yulin Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 81: Wantong Group Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 82: Tianhe Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 83: Shengyang Hongyao Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 84: MUHI Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 85: LKF Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 86: Linrui Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 87: JNJ Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 88: Hubiao Drugs for External Use Revenue Market Share Globally (2019-2021)
Figure 89: Global Drugs for External Use Sales (K Units) Forecast (2023-2029)
Figure 90: Global Drugs for External Use Sales (K Units) Forecast (2023-2029)